May 2021 Articles

Articles
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial
Rubino J, MacDougall DE, Sterling LR, et al.
Journal:
J Clin Lipidol

First published: May 28, 2021 DOI: 10.1016/j.jacl.2021.05.002
View
- Share
Articles
Comparison of the Effects of High-intensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study
Kim K, Bang WD, Han K, et al.
Journal:
J Lipid Atheroscler

First published: May 25, 2021 DOI: 10.12997/jla.2021.10.3.291
View
- Share
Articles
Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic
Chakraborty, A, Pang, J, Chan, DC, et al.
Journal:
Clin Cardiol 2021; 44: 805– 813

First published: May 6, 2021 DOI: 10.1002/clc.23607
View
- Share
Articles
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
StephenJ Nicholls, A Michael Lincoff, Harold E Bays, et al.
Journal:
Am Heart J 2021 May;235:104-112

First published: May 1, 2021 DOI: 10.1016/j.ahj.2020.10.060
View
- Share